841 Non-invasive Imaging of Response to MEK Inhibition With Selumetinib (AZD6244, ARRY-142886) in a Human Colorectal Cancer Xenograft Using Diffusion-Weighted MRI

2012 ◽  
Vol 48 ◽  
pp. S202
Author(s):  
M. Beloueche-Babari ◽  
Y. Jamin ◽  
S. Walker-Samuel ◽  
P.D. Smith ◽  
J.C. Waterton ◽  
...  
2019 ◽  
Vol 87 (June) ◽  
pp. 1631-1637
Author(s):  
NEHAL K. MOHAMED, M.Sc. EMAN A. AHMAD, M.D. ◽  
MOHAMED Z. MOHAMED, M.D. ABO EL-HASSAN H. MOHAMED, M.D.

2016 ◽  
Vol 2 (6) ◽  
pp. 309
Author(s):  
Michelle Leech ◽  
John Gaffney ◽  
Laure Marignol

Prostate cancer represents 11% of all cancers in the European Union and 9% of all cancer deaths. Standard MRI for prostate cancer includes high-resolution T2-weighted images, which allow for the assessment of the prostate and the tumour, as tumours arising from the peripheral zone appear dark compared to the expected normally bright peripheral gland tissue. Over the past number of years, the application of diffusion-weighted MRI (DW-MRI) has progressed to include both diagnostic and prognostic roles in oncology. DW-MRI images should be analysed together with the T2-weighted images and the corresponding apparent diffusion coefficient (ADC) maps. We searched PubMed, Cochrane, and Science Direct for relevant journal articles and reviews published up until April 2015 using the search terms “functional MRI” OR “multiparametric MRI” OR “MRSI” AND “diagnosis” AND “prostate cancer” OR “prostate”. The literature indicates that DW-MRI is an important parameter in the identification of prostate cancer. It has the ability to improve sensitivity and specificity, relative to T2-weighted images alone, and has been demonstrated to correlate with tumour grade.


2001 ◽  
Vol 37 ◽  
pp. S341
Author(s):  
M.R. Pfeffer ◽  
R. Spiegelman ◽  
U. Nisim ◽  
Y. Roth ◽  
S.E. Maier ◽  
...  

Author(s):  
Mina Sameh Sabry ◽  
Amany Emad Eldeen Rady ◽  
Gamal Eldeen Mohamed Niazi ◽  
Susan Adil Ali

Abstract Background The colorectal cancer (CRC) is one of the deadliest cancers in the world. Local tumor stage, vascular or lymphatic invasion, and tumor grade are essential for accurate management. The main imaging modality for initial assessment and therapeutic response evaluation of CRC is magnetic resonance imaging (MRI). The purpose of this prospective study was to illustrate the role of diffusion-weighted MRI (DWI) and apparent diffusion coefficient (ADC) value in initial assessment and grading of colorectal carcinoma as well as evaluation of its response to chemotherapy or combined chemoradiation. Results Restricted diffusion in DWI was found in 37 out of 40 patients with sensitivity of about 92.5%. In the studied group, the median ADC value was 1.21 (min 0.80, max 1.31) and the average ADC value was 1.14 ± 0.161. The mean ADC value in poorly differentiated tumors was 0.979 × 10−3mm2/s. The mean ADC value in moderately differentiated tumors was 1.112 × 10−3mm2/s. The mean ADC value in well-differentiated tumors was 1.273 × 10−3mm2/s. The sensitivity, specificity, PPV, NPV, and accuracy were higher with addition of DWI and ADC value to conventional MRI reaching 100%, 80%, 83.3%, 100%, and 90%, respectively. Conclusion Adding DW imaging with ADC value to conventional MRI yields better diagnostic accuracy than using conventional MR imaging alone in detection, correlation with tumor histologic grade, initial staging, and response evaluation to neoadjuvant chemoradiotherapy in patients with locally advanced colorectal cancer.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Raphaëla Carmen Dresen ◽  
Sofie De Vuysere ◽  
Frederik De Keyzer ◽  
Eric Van Cutsem ◽  
Hans Prenen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document